CHME Stock Price Prediction 2026-2027
AI-powered forecast for China Medicine Corporation
Based on fundamental analysis and historical trends
Current Price
$0.02
Price Targets for 2027
Bear Case
$0.02
-9.0%
Base Case
$0.02
+11.0%
Bull Case
$0.03
+26.0%
Prediction Tracking
Coming Soon for CHME
Tracking begins January 2026
We are building a comprehensive track record of our AI predictions. Check back to see how our forecasts perform against actual results.
Upcoming Events for CHME
Key Factors Influencing CHME Stock
Bullish Factors
- Significant upside potential to bull case target
- Market position and competitive advantages
Risk Factors
- Declining revenue growth of -0.1%
- Market volatility and macroeconomic factors
- Competitive pressures in Medical Distribution
Prediction Methodology
These predictions are generated using fundamental analysis including:
- 0
- Revenue Growth: -0.1%
- Profit Margin: 0.1%
- Return on Equity: 0.1%
Limited analyst coverage available. Consider viewing more research before making investment decisions.
Get Real-Time Analysis
Access live data, AI insights, and detailed valuations for CHME
Frequently Asked Questions
What is CHME stock price today?
CHME (China Medicine Corporation) stock is trading at $0.02 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is CHME stock going up or down today?
CHME stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy CHME stock now?
The decision to buy CHME depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is CHME a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for CHME based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is CHME stock overvalued or undervalued?
Use our DCF valuation calculator to determine if CHME is overvalued or undervalued based on fundamental analysis and future cash flow projections.
What is CHME's P/E ratio?
P/E ratio data for CHME will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.
What is CHME's market cap?
CHME (China Medicine Corporation) has a market capitalization of $0.00 billion, making it a small-cap stock.
What is CHME's price to book ratio?
CHME trades at a price-to-book (P/B) ratio of 0.07, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Does CHME pay dividends?
CHME does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.
What is CHME's dividend yield?
CHME does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.
Is CHME stock a good long-term investment?
CHME's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.
What is CHME's revenue growth rate?
CHME has shown revenue growth of -0.1% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.
Is CHME profitable?
Yes, CHME is profitable with a profit margin of 0.1%. This indicates the company generates 0.1 cents of profit for every dollar of revenue.
What are the risks of investing in CHME?
Key risks for CHME include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.
How does CHME compare to its competitors?
Compare CHME to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CHME's performance and positioning.
What is CHME's stock price target for 2026?
Our AI model provides price targets for CHME based on fundamental analysis: Bull case $0.03 (+30%), Base case $0.02 (+15%), Bear case $0.02 (-10%). Visit our prediction page for detailed forecasts.
What do analysts say about CHME?
Wall Street analysts provide ratings (buy/hold/sell) and price targets for CHME. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.
When is CHME's next earnings report?
CHME reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.